BCM
RDY icon

Bayesian Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Bayesian Capital Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-31,500
Closed -$285K – 646
2016
Q4 		$285K Buy
+31,500
New +$293K 0.07% 438

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bayesian Capital Management's RDY Position: Q1 2017 in Review

Bayesian Capital Management sold out of Dr. Reddy's Laboratories (RDY) in Q1 2017, closing a stake of 31,500 shares — an estimated $285K sold.

Bayesian Capital Management first reported a position in RDY in Q4 2016 and held it in 1 quarter. The position peaked at $285K in Q4 2016. 134 funds tracked by Wall St. Rank hold RDY as of Q1 2017.

  • Bayesian Capital Management reported no remaining Dr. Reddy's Laboratories position as of Q1 2017 after selling out during the quarter.
  • Bayesian Capital Management sold 31,500 Dr. Reddy's Laboratories shares in Q1 2017, an estimated $285K.
  • Bayesian Capital Management first reported a position in Dr. Reddy's Laboratories in Q4 2016 and held it in 1 quarter.
  • Bayesian Capital Management's Dr. Reddy's Laboratories position peaked at $285K in Q4 2016.
  • 134 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2017.

Based on Bayesian Capital Management's 13F filing for Q1 2017, filed 15 May 2017.